Merck KGaA Unveils EUR300 Million Bioprocessing Hub in South Korea

MT Newswires · 10/29 08:46
08:46 AM EDT, 10/29/2026 (MT Newswires) -- Merck KGaA (MRK.F) opened a 300 million-euro bioprocessing production center in Daejeon, South Korea, to boost regional capacity for Asia-Pacific biopharma manufacturers. The 44,500-square-meter facility will manufacture critical materials and tools used for biologic medicine production, supporting early process development through commercial-scale operations, the German science and technology company said Thursday. The site will also utilize solar energy, a heat-pump system, energy recovery in air handling units, and rainwater recycling to improve energy and water efficiency.